
Rbtrix S 250mg/125mg Injection
Marketer
R.B. Remedies Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Rbtrix S 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, curbing infection spread. Administration must be under a doctor's direct guidance; strict adherence to the prescribed schedule is crucial. Complete the full course, regardless of symptom improvement; premature cessation can compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects promptly. Seek immediate medical attention for allergic reactions (e.g., rash, itching, swelling, dyspnea). Inform your physician about all concurrent medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occurs. Rest, proper nutrition, and hydration facilitate recovery. Follow-up laboratory tests may be requested to monitor treatment response.
Primary Ingredients of Rbtrix S 250mg/125mg Injection
The provided text is "undefined," offering no content to rephrase. Therefore, no rewritten text can be provided.
Uses of Rbtrix S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Rbtrix S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Rbtrix S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Rbtrix S 250mg/125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Rbtrix S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Rbtrix S 250mg/125mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a third-generation cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam's role as a beta-lactamase inhibitor counteracts bacterial defenses, optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from using Rbtrix S 250mg/125mg Injection concurrently with alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Rbtrix S (250mg/125mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Rbtrix S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Rbtrix S 250mg/125mg Injection can cause drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Rbtrix S 250mg/125mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
The injectable medication, Rbtrix S 250mg/125mg, requires careful administration to individuals with significant hepatic impairment. Dosage modification for Rbtrix S 250mg/125mg Injection may be necessary; physician consultation is advised. Altering the dose of Rbtrix S 250mg/125mg Injection is unnecessary for patients experiencing mild or moderate liver dysfunction.
What if you forget to take Rbtrix S 250mg/125mg Injection :
Omitting a scheduled dose of Rbtrix S 250mg/125mg Injection requires contacting your physician for guidance.
Facts to Know About Rbtrix S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
